1. Home
  2. TBIO

TBIO

Telesis Bio Inc.

Logo Telesis Bio Inc.

Health Care

Medical Specialities

Nasdaq

as 04-19-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Telesis Bio Inc is a synthetic biology company focused on enabling researchers to rapidly, accurately, and reproducibly build or write high-quality synthetic DNA and mRNA that is ready to use in many downstream synthetic biology-enabled markets. It manufactures and sells laboratory equipment, specifically synthetic biology instruments, reagents, and associated products and related services. Its products comprise of BioXp system, BioXp kits, Benchtop reagents and BioXp biofoundry services.

Founded: 2013 Country:
United States
United States
Employees: N/A City: SAN DIEGO
Market Cap: 11.4M IPO Year: 2021
Target Price: N/A AVG Volume (30 days): 776.0K
Analyst Decision: Hold Number of Analysts: 1
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -1.64 EPS Growth: N/A
52 Week Low/High: $0.30 - $3.19 Next Earning Date: 05-09-2024
Revenue: $27,509,000 Revenue Growth: 0.27%
Revenue Growth (this year): 31.63% Revenue Growth (next year): 30.99%

Share on Social Networks: